晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02228 晶泰控股

清明节翌日休市 04-02 16:08:21

9.600

-0.140

-1.44%

最高9.930	最低9.440	成交量6,179万
今开9.750	昨收9.740	日振幅5.03%
总市值413.09亿	流通市值413.09亿	总股本43.03亿
成交额5.94亿	换手率1.44%	流通股本43.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":9.6,"timestamp":1775117301004,"preClose":9.74,"halted":0,"volume":61786088,"delay":0,"changeRate":-0.01437371663244359,"floatShares":4303000000,"shares":4303000000,"eps":0.03412609336301219,"marketStatus":"清明节翌日休市","change":-0.14,"latestTime":"04-02 16:08:21","open":9.75,"high":9.93,"low":9.44,"amount":594028683,"amplitude":0.050308,"askPrice":9.6,"askSize":162000,"bidPrice":9.59,"bidSize":100000,"shortable":3,"etf":0,"ttmEps":0.03412609336301219,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":7,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":9.74,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":0.8969404832607832,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02228","defaultTab":"news","newsList":[{"id":"2623373124","title":"【券商聚焦】中信证券：基本医保基金收支和结余整体保持稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=2623373124","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623373124?lang=zh_cn&edition=full","pubTime":"2026-03-31 08:59","pubTimestamp":1774918794,"startTime":"0","endTime":"0","summary":"2026年2月医保支出同比增速回升，收支剪刀差有所收窄。该机构预计在医保基金监管力度持续加大，DRG/DIP精细化管理的推动下，2026年全年基金结余率或将延续此前节奏略有提升。医疗健康产业政策改革进入密集期，建议持续关注政策驱动下的医疗健康产业投资机会。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977773","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1719994722.HKD","600030","BK1583","02367","09926","LU0348766576.USD","BK1515","BK1191","01099","BK1100","01789","LU0348735423.USD","BK1147","LU2148510915.USD","03933","02196","BK0012","BK1588","LU2495084118.USD","HK0000165453.HKD","02268","LU1303224171.USD","09688","LU1969619763.USD","LU2476274308.USD","LU0634319403.HKD","LU1115378108.SGD","LU1255011170.USD","BK1161","LU1770034418.SGD","LU1997245177.USD","BK0028","LU0348783233.USD","LU1328615791.USD","IE00B543WZ88.USD","BK1617","LU2399975544.HKD","06160","BK1593","IE00BPRC5H50.USD","LU0405327148.USD","LU0405327494.USD","01530","LU0307460666.USD","06030","LU2488822045.USD","02228","BK1564","06821","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622446802","title":"如何解读晶泰控股这份“扭亏为盈”财报？","url":"https://stock-news.laohu8.com/highlight/detail?id=2622446802","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622446802?lang=zh_cn&edition=full","pubTime":"2026-03-28 10:46","pubTimestamp":1774666016,"startTime":"0","endTime":"0","summary":"3月25日，中国AI制药“第一股”晶泰控股披露了2025年全年业绩公告，交出了一份亮眼的“扭亏”答卷。今天，我们将从纯财务视角出发，层层拆解，还原晶泰控股“扭亏为盈”的真实面貌。这笔 5100 万美元首付款，成为晶泰控股实现 “扭亏” 的重要支撑，而 4900 万美元里程碑款并未计入本次财报。02 核心主业持续向好尽管晶泰控股本次扭亏并非依靠持续经营业务驱动，但其核心业务基本面确实呈现持续向好态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774582771818978437","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622281595","title":"晶泰控股2025年营收8亿：经营利润5524万 刚发行29亿港元债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2622281595","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622281595?lang=zh_cn&edition=full","pubTime":"2026-03-27 09:41","pubTimestamp":1774575672,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司（简称：“晶泰控股”，股票代码：“2228”）日前发布截至2025年12月31日的财报。财报显示，晶泰控股2025年营收为8亿元，较上年同期的2.66亿元增长201%。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260327/6391020126839380581981730.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260327/6391020126839380581981730.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33072/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622285725","title":"晶泰科技2025年年报出炉：首次盈利，AI for Science进入价值兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2622285725","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622285725?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:18","pubTimestamp":1774527517,"startTime":"0","endTime":"0","summary":"3月25日晚，晶泰控股（2228.HK）发布2025年全年业绩报告。数据显示，公司全年营收达8.03亿元，同比增加201.2%。报告期内，公司首次实现年度盈利，也成为AI应用领域率先盈利的港股上市公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603263685820583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02228","BK1617","BK1141","AIPO","CHAT","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622783996","title":"“AI制药”的晶泰控股扭亏虚与实","url":"https://stock-news.laohu8.com/highlight/detail?id=2622783996","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622783996?lang=zh_cn&edition=full","pubTime":"2026-03-26 14:52","pubTimestamp":1774507932,"startTime":"0","endTime":"0","summary":"港股“AI制药明星企业”晶泰控股交出了上市以来的首份扭亏答卷。\n2025年，晶泰控股实现营业收入8....","market":"other","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3768447","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“AI制药”的晶泰控股扭亏虚与实","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","AIPO","01477","BK1141","02228","AGIX","BK1191","CHAT","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173204622","title":"异动解读 | 晶泰控股盘中大涨5.18%，首次全年盈利及AI平台商业化进展提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1173204622","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173204622?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:38","pubTimestamp":1774489112,"startTime":"0","endTime":"0","summary":"晶泰控股今日盘中大涨5.18%，引起了市场的广泛关注。消息面上，公司于3月25日发布了2025年年度业绩报告，首次实现全年盈利，成为AI for Science领域首家盈利的港股上市公司。同时，晶泰控股近期与DoveTree达成了一项总订单规模约470亿港元的管线合作，并获得了约4亿港元首付款，创下了人工智能新药研发领域订单规模的新纪录。公司还在大分子药物研发领域与礼来达成总额达3.45亿美元的多靶点战略合作及平台授权协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e1d988722ff66852c525a3ca4fcad38d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622022284","title":"晶泰控股(02228)发布年度业绩，股东应占利润1.24亿元 同比扭亏为盈 在AI应用领域稳居行业领先地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2622022284","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622022284?lang=zh_cn&edition=full","pubTime":"2026-03-25 18:28","pubTimestamp":1774434519,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股 发布截至2025年12月31日止年度业绩，该集团取得收入人民币8.03亿元，同比增加201.25%;公司权益持有人应占年内利润人民币1.24亿元，同比扭亏为盈;每股盈利人民币3分。公告称，集团首次实现年度盈利，也成为AI for Science领域首家盈利的港股上市公司。截至2025年12月31日集团现金余额合计人民币70.69亿元，2026年集团新发可转债净额人民币25.37亿元，充沛的资金储备为持续研发投入提供硬核保障，进一步巩固晶泰在AI4S领域的行业领先地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK4588","BK4585","BK1141","AIQ","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153105363","title":"晶泰控股2025年度收入大幅提升并成功扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1153105363","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153105363?lang=zh_cn&edition=full","pubTime":"2026-03-25 18:25","pubTimestamp":1774434326,"startTime":"0","endTime":"0","summary":"晶泰控股于2025年度实现收入约8.03亿元，较2024年的2.66亿元大幅增长。其中，“药物发现解决方案”板块从1.04亿元增至5.38亿元，“AI for Science智慧解决方案”则由1.63亿元上升至2.65亿元。同期营业成本为2.43亿元，研发投入亦从4.18亿元提升至5.69亿元，一般及行政开支小幅下降至4.10亿元，销售及营销开支则增至0.81亿元。综合来看，公司在2025年大幅扩张主营业务规模并实现盈利转变，整体财务状况随权益规模扩张而得到进一步增强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621095723","title":"【券商聚焦】交银国际：CXO行情持续回暖 料板块估值倍数合理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095723","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621095723?lang=zh_cn&edition=full","pubTime":"2026-03-23 10:25","pubTimestamp":1774232735,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，多重利好因素共振下，2025年以来CXO行情持续回暖。该机构建议重点关注标的细分赛道成长力、核心能力布局、盈利和订单增长能见度、地缘风险敞口及估值上升空间。基于此，该机构首推药明合联，首次覆盖并重点推荐凯莱英和康龙化成。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228","01099","01530","02196","LU2476274720.SGD","LU0417516571.SGD","BK1141","BK1500","LU1770034418.SGD","LU2778985437.USD","LU0348827113.USD","LU0417516902.SGD","LU2328871848.SGD","06821","LU2399975544.HKD","BK1588","09926","03329","LU2488822045.USD","IE00B543WZ88.USD","09688","LU0348735423.USD","LU0634319403.HKD","LU0307460666.USD","LU0348767384.USD","LU0348766576.USD","BK1583","LU1115378108.SGD","LU1303224171.USD","CXO","BK1585","BK1197","02268","02367","06160","BK1574","LU0540923850.HKD","LU2476274308.USD","BK1191","BK1593","BK1617","BK1161","IE00BPRC5H50.USD","01789","LU1719994722.HKD","LU1794554557.SGD","BK1207","03933","LU0348784397.USD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619348894","title":"港股异动 | 晶泰控股(02228)现涨超4% 2025年度首次盈利 稀缺AI制药平台价值加速兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2619348894","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619348894?lang=zh_cn&edition=full","pubTime":"2026-03-16 14:27","pubTimestamp":1773642425,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰控股现涨超4%，截至发稿，涨4%，报9.88港元，成交额3.83亿港元。消息面上，晶泰控股此前发布盈喜，预计公司2025年度实现营收不少于7.8亿元，同比增长超193%；归母净利润不少于1亿元，同比扭亏为盈，首次实现全年盈利。国联民生发布研报称，2025年业绩亮眼，稀缺AI制药平台价值加速兑现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3923f54d12d0c12982608f5f8a99e8da","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK1191","BK1617","01477","BK4588","BK1141","BK1574","BK4585","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618979251","title":"每日卖空追踪 | 晶泰控股 03月11日卖空量成交94.8万股，卖空比例为3.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618979251?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217829,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间03月11日，跌1.2%，卖空量成交94.8万股，较上一交易日减少85.3%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163353a6b794f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163353a6b794f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618979298","title":"晶泰控股03月11日主力净流出1637.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618979298?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:16","pubTimestamp":1773216961,"startTime":"0","endTime":"0","summary":"03月11日, 晶泰控股股价跌1.20%，报收9.90元，成交金额3.0亿元，换手率0.69%，振幅2.59%，量比0.44。晶泰控股今日主力资金净流出1637.8万元，上一交易日主力净流入941.4万元。该股近5个交易日上涨3.24%，主力资金累计净流入1162.3万元；近20日主力资金累计净流出1.7亿元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162134a460ac60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162134a460ac60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618193105","title":"晶泰控股(02228)委任周斐然为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2618193105","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618193105?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:54","pubTimestamp":1773140068,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股(02228)公布，周斐然先生由2026年3月10日起获委任为公司首席财务官。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK1617","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618915325","title":"晶泰控股03月10日主力净流入941.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2618915325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618915325?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:15","pubTimestamp":1773130547,"startTime":"0","endTime":"0","summary":"03月10日, 晶泰控股股价涨2.87%，报收10.02元，成交金额5.3亿元，换手率1.25%，振幅3.18%，量比0.75。晶泰控股今日主力资金净流入941.4万元，上一交易日主力净流出2092.0万元。该股近5个交易日上涨5.24%，主力资金累计净流出563.1万元；近20日主力资金累计净流出1.4亿元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161909a6b4c7f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161909a6b4c7f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618620120","title":"每日卖空追踪 | 晶泰控股 03月09日卖空量成交804.7万股，卖空比例为10.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618620120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618620120?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045029,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间03月09日，跌3.18%，卖空量成交804.7万股，较上一交易日减少8.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163349a6b1c77f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163349a6b1c77f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618461976","title":"国泰海通：AI制药持续进展 跨国药企布局加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2618461976","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618461976?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:21","pubTimestamp":1773044509,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国泰海通发布研报称，随着AI在靶点发现、分子生成、临床设计及上市后数据分析中的全面渗透，行业渗透率持续提升，AI+制药正成为创新药研发的重要基础设施。国泰海通主要观点如下：AI+制药重塑研发范式，行业从概念迈入实效验证期生成式模型与强化学习的深度融合，显著提升分子设计效率，缩短研发周期。整体来看，AI正在成为药物研发体系升级的核心变量。在人工智能与医药双领域共振下，看好AI+制药发展前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK0028","BK0184","BK0276","BK0188","02611","BK1147","BK1191","BK1617","BK1141","601211","BK1564","BK1574","01477","BK0183","01873","03696","BK0201","BK1576","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618124620","title":"【券商聚焦】西南证券：晶泰控股(2228.HK)AI驱动创新，首次覆盖建议关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2618124620","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618124620?lang=zh_cn&edition=full","pubTime":"2026-03-09 11:59","pubTimestamp":1773028744,"startTime":"0","endTime":"0","summary":"金吾财讯|西南证券发布研报指，晶泰控股当前价9.54港元，作为AI for Science核心标的，近期实现跨越式进展。行业层面，全球AI药物研发企业超900家，TOP20药企均布局AI研发管线。药物发现外包市场增速显著，2023-2030年全球CAGR 14.9%，中国达19.6%。个股方面，公司量子物理+AI+机器人三位一体平台覆盖小分子、抗体等全链条研发，XtalFold抗体平台准确率提升10%。风险提示创新药商业化及政策变化风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309120850a6b10e05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309120850a6b10e05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618361996","title":"晶泰控股盘中异动 早盘大幅跳水5.17%报9.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618361996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618361996?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:31","pubTimestamp":1773019883,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时31分，晶泰控股股票出现异动，股价快速下跌5.17%。截至发稿，该股报9.540港元/股，成交量359.8万股，换手率0.08%，振幅1.99%。资金方面，该股资金流入1106.26万港元，流出1447.23万港元。晶泰控股股票所在的生物技术行业中，整体跌幅为1.93%。其相关个股中，科济药业-B、派格生物医药-B、维立志博-B涨幅较大，振幅较大的相关个股有科济药业-B、药捷安康-B、派格生物医药-B，振幅分别为15.55%、9.51%、8.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093123a459a1b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093123a459a1b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617919503","title":"【券商聚焦】交银国际：医药公司业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617919503","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617919503?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:08","pubTimestamp":1772759313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，2026年以来，内资通过港股通持有医药股的比例呈现先降后升态势，当前水平与年初持平，外资持仓则有所提升。本周内资继续加仓创新药产业链和器械标的，外资则重点布局创新药企及CXO企业。年报季临近，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976027","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228","HK0000165453.HKD","LU1961090484.USD","LU0348783233.USD","BK1191","LU0561508036.HKD","LU2399975544.HKD","IE00BPRC5H50.USD","BK1515","LU1115378108.SGD","LU0588546209.SGD","09939","BK1197","09926","BK1574","LU2476274308.USD","IE00B5MMRT66.SGD","LU1719994722.HKD","LU0348766576.USD","01789","BK1141","BK1585","BK1593","LU1794554557.SGD","SG9999014674.SGD","LU0348825331.USD","01099","01530","LU2328871848.SGD","LU2488822045.USD","LU1303224171.USD","LU1770034418.SGD","LU0540923850.HKD","LU2778985437.USD","LU0640798160.USD","03933","SG9999004311.SGD","09688","02268","LU0348735423.USD","LU0348784397.USD","02196","02367","03329","159938","06160","LU0348827113.USD","BK1207","LU0417516571.SGD","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617210523","title":"每日卖空追踪 | 晶泰控股 03月05日卖空量成交473.5万股，卖空比例为9.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617210523","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617210523?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699429,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间03月05日，涨1.67%，卖空量成交473.5万股，较上一交易日减少62.1%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163354a44ef7ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163354a44ef7ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":0.0356},{"period":"1month","weight":0.0063},{"period":"3month","weight":-0.039},{"period":"6month","weight":-0.3425},{"period":"1year","weight":0.6552},{"period":"ytd","weight":0.0148}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}